INTRODUCTION AND HYPOTHESIS: To estimate the risk of repeat surgery for recurrent prolapse or mesh removal after vaginal mesh versus native tissue repair for anterior vaginal wall prolapse. METHODS: We utilized longitudinal, adjudicated, healthcare claims from 2005 to 2010 to identify women ≥18 years who underwent an anterior colporrhaphy (CPT 57420) with or without concurrent vaginal mesh (CPT 57267). The primary outcome was repeat surgery for anterior or apical prolapse or for mesh removal/revision; these outcomes were also analyzed separately. We utilized Kaplan-Meier curves to estimate the cumulative risk of each outcome after vaginal mesh versus native tissue repair. Cox proportional hazards models were used to estimate the hazard ratio (HR) for vaginal mesh versus native tissue repair, adjusted for age, concurrent hysterectomy, and concurrent or recent sling. RESULTS: We identified 27,809 anterior prolapse surgeries with 49,658 person-years of follow-up. Of those, 6,871 (24.7%) included vaginal mesh. The 5-year cumulative risk of any repeat surgery was significantly higher for vaginal mesh versus native tissue (15.2 % vs 9.8 %, p <0.0001) with a 5-year risk of mesh revision/removal of 5.9%. The 5-year risk of surgery for recurrent prolapse was similar between vaginal mesh and native tissue groups (10.4 % vs 9.3 %, p = 0.70. The results of the adjusted Cox model were similar (HR 0.93, 95%CI: 0.83, 1.05). CONCLUSIONS: The use of mesh for anterior prolapse was associated with an increased risk of any repeat surgery, which was driven by surgery for mesh removal. Native tissue and vaginal mesh surgery had similar 5-year risks for surgery for recurrent prolapse.
INTRODUCTION AND HYPOTHESIS: To estimate the risk of repeat surgery for recurrent prolapse or mesh removal after vaginal mesh versus native tissue repair for anterior vaginal wall prolapse. METHODS: We utilized longitudinal, adjudicated, healthcare claims from 2005 to 2010 to identify women ≥18 years who underwent an anterior colporrhaphy (CPT 57420) with or without concurrent vaginal mesh (CPT 57267). The primary outcome was repeat surgery for anterior or apical prolapse or for mesh removal/revision; these outcomes were also analyzed separately. We utilized Kaplan-Meier curves to estimate the cumulative risk of each outcome after vaginal mesh versus native tissue repair. Cox proportional hazards models were used to estimate the hazard ratio (HR) for vaginal mesh versus native tissue repair, adjusted for age, concurrent hysterectomy, and concurrent or recent sling. RESULTS: We identified 27,809 anterior prolapse surgeries with 49,658 person-years of follow-up. Of those, 6,871 (24.7%) included vaginal mesh. The 5-year cumulative risk of any repeat surgery was significantly higher for vaginal mesh versus native tissue (15.2 % vs 9.8 %, p <0.0001) with a 5-year risk of mesh revision/removal of 5.9%. The 5-year risk of surgery for recurrent prolapse was similar between vaginal mesh and native tissue groups (10.4 % vs 9.3 %, p = 0.70. The results of the adjusted Cox model were similar (HR 0.93, 95%CI: 0.83, 1.05). CONCLUSIONS: The use of mesh for anterior prolapse was associated with an increased risk of any repeat surgery, which was driven by surgery for mesh removal. Native tissue and vaginal mesh surgery had similar 5-year risks for surgery for recurrent prolapse.
Authors: Mariëlla I Withagen; Alfredo L Milani; Jan den Boon; Harry A Vervest; Mark E Vierhout Journal: Obstet Gynecol Date: 2011-02 Impact factor: 7.661
Authors: Kari Nieminen; Reijo Hiltunen; Teuvo Takala; Eila Heiskanen; Mauri Merikari; Kirsti Niemi; Pentti K Heinonen Journal: Am J Obstet Gynecol Date: 2010-05-21 Impact factor: 8.661
Authors: Jacqueline Leme Lunardelli; Antonio Pedro Flores Auge; Nucélio Luiz de Barros Moreira Lemos; Silvia da Silva Carramão; André Lima de Oliveira; Eliana Duarte; Tsutomu Aoki Journal: Rev Col Bras Cir Date: 2009-07
Authors: Vivian W Sung; Rebecca G Rogers; Joseph I Schaffer; Ethan M Balk; Katrin Uhlig; Joseph Lau; Husam Abed; Thomas L Wheeler; Michelle Y Morrill; Jeffrey L Clemons; David D Rahn; James C Lukban; Lior Lowenstein; Kimberly Kenton; Stephen B Young Journal: Obstet Gynecol Date: 2008-11 Impact factor: 7.661
Authors: Demisew Amenu Sori; Stephan Bretones; Georges Mellier; Bertrand de Rochambeau Journal: BMC Womens Health Date: 2022-10-07 Impact factor: 2.742